Article
FDA grants AVR-RD-04 rare pediatric disease designation for cystinosis
Rating:
0.0
Views:
89
Likes:
1
Library:
1
AVROBIO's AVR-RD-04 therapy has been granted rare pediatric disease designation to treat cystinosis in pediatric patients.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value